Overviews of the New Drug in 2017 Approved by U.S. FDA

Overviews of the New Drug in 2017 Approved by U.S. FDA

Lü Xunlei1, GUO Linlin2, ZHOU Weicheng1*

PDF(8701 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(8701 KB)

Chinese Journal of Pharmaceuticals ›› 2018, Vol. 49 ›› Issue (01) : 1. DOI: 10.16522/j.cnki.cjph.2018.01.001

Perspectives & Review

Overviews of the New Drug in 2017 Approved by U.S. FDA

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 49(01): 1 https://doi.org/10.16522/j.cnki.cjph.2018.01.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(8701 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉